Primary Total Hip Arthroplasty in Patients With Ankylosing Spondylitis
Overview
Authors
Affiliations
Background: Ankylosing spondylitis (AS) is a common inflammatory spondyloarthropathy with hip involvement in 40% of patients. With the renewed interest in the hip-spine interplay, this study aimed to define long-term outcomes of primary total hip arthroplasty (THA) in the setting of AS.
Methods: We identified 309 hips (219 patients) with AS treated with primary THA from 1969 to 2018. Mean age was 49 years, 80% were males, and mean body mass index was 28 kg/m. Cumulative incidences of any revision, reoperation, and dislocation were calculated utilizing a competing risk analysis. Harris Hip Scores and complications were also reported. Mean follow-up was 16 years.
Results: The cumulative incidence of any revision after primary THA was 2.3% at 5 years and 17.5% at 20 years. The most common reasons for revision (n = 73) were aseptic loosening (41%), osteolysis/polyethylene (PE) wear (30%, all with conventional PE), and femoral component fracture (8%). The cumulative incidence of dislocation was 1.9% at 5 years and 2.9% at 20 years. Younger age was associated with increased risk of revision (hazard ratio (HR) = 1.3, P < .01) and reoperation (HR = 1.2, P < .01), but not dislocation (HR = 0.7, P = .1). Twenty-eight hips (9%) experienced a postoperative complication not requiring reoperation. The mean Harris Hip Score improved from 51 to 76 after THA (P < .001).
Conclusion: In this series of 309 primary THAs in patients with AS, the 20-year cumulative incidence of any revision after primary THA was 17.5%. Aseptic loosening, osteolysis/PE wear, and femoral component fracture were the most common reasons for revision. Notably, the cumulative incidence of dislocation at 20 years was only 2.9%.
Level Of Evidence: Level IV.
Li L, Fu J, Xu C, Ni M, Chai W, Hao L BMC Musculoskelet Disord. 2025; 26(1):121.
PMID: 39910531 PMC: 11796053. DOI: 10.1186/s12891-025-08369-6.
Li X, Pan J, Li H, Zhang J, Pan F, Man S Clin Rheumatol. 2025; 44(3):1135-1140.
PMID: 39869259 DOI: 10.1007/s10067-025-07338-7.
Li L, Fu J, Xu C, Ni M, Chai W, Hao L J Orthop Surg Res. 2024; 19(1):877.
PMID: 39726010 PMC: 11670520. DOI: 10.1186/s13018-024-05318-2.
Falgiano P, Rowland R, Heifner J, Corces A Int J Surg Case Rep. 2024; 122:110161.
PMID: 39159594 PMC: 11382324. DOI: 10.1016/j.ijscr.2024.110161.
Literature review of non-pharmacological treatment for patients with axial spondyloarthritis.
Yeo J, Seo M, Park J, Lee Y, Lee J, Kang E Korean J Intern Med. 2024; 40(1):40-48.
PMID: 38798046 PMC: 11725484. DOI: 10.3904/kjim.2023.485.